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Abstract
Background: Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae commonly cause
infections worldwide. BlaCTX-M-15 has been commonly detected in hospital isolates in Mwanza, Tanzania. Little is
known regarding the faecal carriage of ESBL isolates and blaCTX-M-15 allele among humans in the community in
developing countries.
Methods: A cross-sectional study involving 334 humans from the community settings in Mwanza City was
conducted between June and September 2014. Stool specimens were collected and processed to detect ESBL
producing enterobacteriaceae. ESBL isolates were confirmed using disc approximation method, commercial ESBL
plates and VITEK-2 system. A polymerase chain reaction and sequencing based allele typing for CTX-M ESBL
genes was performed to 42 confirmed ESBL isolates followed by whole genome sequence of 25 randomly
selected isolates to detect phylogenetic groups, sequence types plasmid replicon types.
Results: Of 334 humans investigated, 55 (16.5 %) were found to carry ESBL-producing bacteria. Age, history of
antibiotic use and history of admission were independent factors found to predict ESBL-carriage. The carriage
rate of ESBL-producing Escherichia coli was significantly higher than that of Klebsiella pneumoniae (15.1 % vs.
3.8 %, p = 0.026). Of 42 ESBL isolates, 37 (88.1 %) were found to carry the blaCTX-M-15 allele. Other transferrable
resistance genes were aac(6’)Ib-cr, aac(3)-IIa, aac(3)-IId, aadA1, aadA5, strA, strB and qnrS1. Eight multi-locus
sequence types (ST) were detected in 25 E. coli isolates subjected to genome sequencing. ST-131 was detected
in 6 (24 %), ST-38 in 5 (20 %) and 5 (20 %) clonal complex − 10(ST-617, ST-44) of isolates. The pathogenic phylogenetic
groups D and B2 were detected in 8/25 (32 %) and 6/25 (24 %) of isolates respectively. BlaCTX-M-15 was found to be
located in multiple IncY and IncF plasmids while in 13/25(52 %) of cases it was chromosomally located.
Conclusion: The overlap of multi-drug resistant bacteria and diversity of the genotypes carrying CTX-M-15 in the
community and hospitals requires an overall approach that addresses social behaviour and activity, rationalization of
the antibiotic stewardship policy and a deeper understanding of the ecological factors that lead to persistence and
spread of such alleles.
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Enterobacteriaceae are currently a major problem in
hospitalized patients worldwide [1–3]. The prevalence
of ESBLs among clinical isolates varies between coun-
tries and from institution to institution [2, 4]. Tanzania
is one of the sub-Saharan African countries facing in-
creasing numbers of health care associated infections
due to multi-drug resistant Gram-negative bacteria [5–8].
Data regarding ESBL isolates in Tanzania are limited to
tertiary hospital based studies only.
Several studies performed in developed countries
have demonstrated ESBL carriage in the community
[9–13]. In addition, in many studies from developed
and middle-income countries it could be demonstrated
that ESBL-producing bacteria are common in domestic
and companion animals in the community [14, 15].
Human to animal contact seems to play a role in the
transfer of ESBL producing bacteria between both pop-
ulations [14, 16, 17]. In Thailand, different factors such
as better education, history of hospitalization and the
use of antibiotics have been found to be independently
predictors for ESBL carriage [18]. Despite the potential
risk of ESBL acquisition in the community and transfer
between humans and animals there is no study which
has documented ESBL carriage and associated risk fac-
tors in the human community in Tanzania. Therefore
this study was done to investigate the magnitude of
ESBL carriage and diversity of ESBL genotypes, and to
identify factors associated with it among humans in the
community in Mwanza.
Methods
Sample size and sampling
A cross-sectional study was conducted between June and
September 2014 in three rural districts (Igogo, Mbugani
and Kirumba) with squatters in Mwanza city. The charac-
teristics of the rural districts are described in Table 1.
Sample size was calculated using the formula by Cochran
[19]. A prevalence of 22.1 % from a study performed in
Madagascar was used for calculation [20]. The minimum
sample size obtained was 297.
Streets within these rural districts with characteristics of
squatter settlements were purposively selected. A total of
3144 households were obtained from these streets. The
number of households in each street was obtained from
the household registers at the street Executive Officer‘s
office. Simple random sampling was used to select 334
households which were included in the study. Using a
random number generator, the households to be included
in the study were determined. A total of 334 stool samples
(one per participant) were collected. From every partici-
pant enrolled, additional information (with the use of an
interview questionnaire) such as age, gender, size of the
family, history of antibiotic use in the past one month and
history of admission in the past one year, were collected.
Laboratory procedures
A total of 334 non-repetitive stool specimens were ob-
tained from humans. All specimens were cultured on
MacConkey agar supplemented with 2 μg/mL cefotaxime
(Oxoid, Basingstoke, UK) and plain MacConkey agar
plates to isolate lactose fermenting colonies to investigate
these for the antimicrobial susceptibility pattern.
Strain selection
One colony from predominant morphologically similar
colonies was selected on the MacConkey agar plate with
2 μg/mL cefotaxime for subsequent characterization while
a representative of predominant morphologically similar
lactose fermenter colonies was also selected from a plain
MacConkey agar plate.
ESBL confirmation and susceptibility testing
ESBL isolates were confirmed using disc approximation
method as previously described [5], commercial ESBL
CHROMagar (CHROMagar Company, Paris, France) and
VITEK-2 compact system (AST-card N214 and N248,
Table 1 Profile of Igogo, Mbugani and Kirumba
Variables Igogo Mbugani Kirumba
Population size 27,303 39,041 29,354
Number of hospitals/Dispensaries 2 5 4
Number of pharmacy/Medicine shops 18 10 4
Population per pharmacy/medicine shops 1516.8 3904.1 7338.5
Industrial activities • Industrial areas
• Car garages
• Storages warehouses
• None • Car garages
Type of toilets Latrines Latrines Latrines
Damping ground Present Present Present
Distance from Tertiary hospital (Bugando Medical Centre) 1.56 km 2.16 km 3.82 km
ESBL rates 20.5 % 15.2 % 11.6 %
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bioMérieux, Nürtingen, Germany) in case of ambiguous
results. Antimicrobial susceptibility testing using cipro-
floxacin (5 μg), gentamicin (10 μg), tetracycline (30 μg)
and trimethoprim/sulphamethoxazole (1.25/23.75 μg) was
performed with all isolates based on Clinical Laboratory
Standard Institute (CLSI) Guidelines [21].
Analysis of the CTX-M-Allele
A total of 42 ESBL-producing isolates were available for
further characterization. First, the presence of CTX-M
was identified using CTX-M-F (sequence: 5’-TCTTCCA
GAATAAGGAATCCC-3’) and CTX-M-R (sequence: 5’-
CCGTTTCCGCTATTACAAAC-3’) amplifying 909 bp
of the blaCTX-M gene. In case of ambiguities and add-
itional set of primers (CTF-F: 5’-GACAGACTATT
CATGTTGTTG-3’ and CTF-R: 5’-CGATTGCGGAAA
AGCACGTC-3’) was used to differentiate blaCTX-M-15
from blaCTX-M-28. All CTX-M products were sequenced
with both forward and reverse primers using the auto-
mated sequencer ABI Prism® 3100 (Life technologies,
Road Grand Island, USA). The blastN algorithm of
NCBI (http://www.ncbi.nlm.nih.gov/blast/) was to iden-
tify the ESBL alleles.
SHV-F (5’-GCAAAACGCCGGGTTATTC-3’) and SHV-R
(5’-GGTTAGCGTTGCCAGTGCT-3’) were used to amplify
940 bp of the blaSHV gene. PCR using the primers
TEM-F (5’-ATGAGTATTCAACATTTCCG-3’) and TEM-R
(5-TTAATCAGTGAGGCACCTAT-3’) was used to
amplify 851 bp of the blaTEM gene [22].
Whole genome sequencing
Twenty five CTX-M-15-producing Escherichia coli strains
were randomly selected for whole genome sequencing
(WGS). Genomic DNA was isolated using Purelink
Genome DNA Mini kit (Invitrogen, Darmstadt, Germany)
according to the manufacturer’s instruction. WGS was
carried out on an Illumina MiSeq instrument (Illumina,
San Diego, CA, USA) with an Illumina Nextera XT library
with 2x300bp paired-end reads. The reads were assembled
using SPAdes (version 3.0) [23]. The assembled contigs
were analysed and examined for the presence of transfer-
rable resistance genes, virulence genes, multi-locus se-
quence types, and plasmid replicon types using ResFinder,
VirulenceFinder, MLST 2.0, and PlasmidFinder software,
[24–27], respectively.
The location of blaCTX-M-15 was determined by extract-
ing the contigs harbouring blaCTX-M-15 and studying the
genes flanking blaCTX-M-15 gene using NCBI blast (http://
blast.ncbi.nlm.nih.gov/Blast.cgi).
Data analysis
Data were double-entered into Microsoft Excel and ana-
lysed using STATA version 11. Results were summarized
using proportions (%) for categorical data and medians
(IQR) for continuous variables. Categorical variables were
compared using either Pearson’s Chi–squared or Fisher’s
exact test, where appropriate. To determine the predictors
of ESBL carriage, univariate followed by multivariate logis-
tic regressions analysis was performed. The predictors
tested included age, sex, number of residents in a house-
hold, antibiotic use in the last month, admission history
and presence of animals at home. Odd ratios with respect-
ive 95 % confidence interval (CI) were reported. Predictors
with a p-value of less than 0.05 were considered statisti-
cally significant.
Limitations of the study
In this study the primers pair used are not for amplifica-
tion of all CTX-M groups, and might have introduced a
great bias towards group 1 to which CTX-M-15 belongs.
However, the sequence covered aligned clearly align to the
product with CTX-M-15 standard and this was further
confirmed for the 25 isolates which underwent WGS. The
WGS of 25 randomly selected isolates also confirmed the
presence CTX-M-15 in all 25 isolates. Finally, 13 ESBL
isolates could not be recovered for PCR and sequencing.
Results
Demographic
Of 334 humans sampled, 196 (58.7 %) were female. The
median age was ten years (IQR 5–23). All sampled par-
ticipants used tap water. The median number of children
in a household was three (IQR 2–4). The majority of
participants 156/334 (46.7 %) were from Igogo rural dis-
trict (Table 1).
ESBL carriage and rates of ESBL by isolates
Of 334 individuals from the Mwanza city community, 55
(16.5 %) were found to be colonized by ESBL-producing
Enterobacteriaceae. A total of 323 lactose fermenting
isolates (270 E. coli and 53 Klebsiella pneumoniae) were
obtained from plain MacConkey agar plates. Out of E. coli
and Klebsiella pneumoniae isolates, 42/270 (15.5 %) and
2/53 (3.8 %) were ESBL producers, respectively (p =
0.026). E. coli (42/55; 76.3 %) formed the majority of ESBL
isolates in this population. A total of eleven ESBL isolates
were other Enterobacteriaceae species (Enterobacter spp:
n = 4, Proteus mirabilis: n = 5 and Proteus vulgaris: n = 2).
Their ESBL rates could not be calculated because these
isolates were not targeted for in using plain MacConkey
agar plates.
Susceptibility pattern
A total of 279 (E. coli, 228 and Klebsiella pneumoniae, 51)
non-ESBL isolates and 55 ESBL isolates from humans
stool specimens were obtained. The 55 ESBL isolates
were significantly more resistant to trimethoprim/sulpha-
methoxazole (SXT), tetracycline (TET), gentamicin (CN)
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and ciprofloxacin (CIP) than the non-ESBL isolates;
Table 2 (p < 0.001). All isolates were sensitive to ertape-
nem, meropenem, imipenem and tigecycline. The resist-
ance rates of the isolates to TET, SXT, CN and CIP were
48.8 %, 64.9 %, 14.4 % and 12.9 % respectively.
Predictors of ESBL carriage
Higher median age was observed among individuals colo-
nized with ESBLs compared to those without colonization
(17 [IQR 6–38] vs. 10 [IQR 5–22], p = 0.028). On univariate
analysis, the ESBL carriage significantly increased with the
number of children in the household (OR = 1.34, 95 % CI
1.14–1.57, p < 0.001). Humans from Igogo were signifi-
cantly more colonized by ESBL-producing isolates than
those from Kirumba on univariate analysis (OR = 1.9, 95 %
CI 1.0–4.2, p = 0.05).
Of 208 individuals who had a history of using antibiotics
in the past one month, 44 (21.1 %) were found to be colo-
nized with ESBL isolates as compared to 11 (8.7 %) of
those with no history of antibiotic use (OR = 2.88, 95 % CI
1.3–5.66, p = 0.004). In addition, significantly higher rate
of colonization was observed among individuals with his-
tory of admission in the past one year compared to those
with no history (66.6 % vs. 15.1 %; p = 0.001).
On multivariate logistic regression analysis only history
of admission, history of antibiotic use and increasing age
were independent predictors of ESBL carriage (Table 3).
ESBL alleles and resistance genes
Of 42 ESBL isolates available for typing, 37 (88.1 %)
were found to carry the blaCTX-M-15 allele. Of these, 34
(91.8 %) were E. coli, two Klebsiella pneumoniae and
one Enterobacter spp. The remaining five ESBL isolates
(three E. coli isolates and two Enterobacter spp.) were
not positive for CTX-M group 1 alleles. Further screen-
ing for the presence of SHV- and TEM-type ESBL-genes
was negative. The whole genome sequence of 25 ran-
domly selected E. coli strains confirmed all to harbour
blaCTX-M-15. Analysis of the sequenced isolates revealed
that in 13/25 isolates CTX-M-15 was found to be
located in the chromosome.
Several other transferrable resistance genes were de-
tected in the sequenced E. coli genomes. Aminoglyco-
side resistance genes detected were strA/strB (18/25,
72 %), aadA5 (16/25, 64 %), aac(6’)Ib-cr (17/25, 68 %),
aac(3)-IIa (12/25, 48 %), aadA1 (5/25, 20 %) and
aac(3)-IId (6/25, 24 %). Quinolone resistance genes
detected were aac(6’)Ib-cr (17/25, 68 %) and qnrS1 (6/
25, 24 %) (Table 4). All sequenced isolates carried tri-
methoprim and sulphamethoxazole resistance genes.
Table 2 Resistance rates of ESBL and Non-ESBL isolates to TET,








Tetracycline 119 (42.7 %) 44 (80 %) 163 (48.8 %) p < 0.001
Ciprofloxacin 6 (2.1 %) 37 (67.2 %) 43 (12.9 %) p < 0.001
Gentamicin 14 (5.2 %) 34 (61.8 %) 48 (14.4 %) p < 0.001
Co-trimoxazole 184 (66.6 %) 52 (94.5 %) 216 (64.7 %) p < 0.001
SXT Trimethoprim/sulphamethoxazole, TET tetracycline, CN gentamicin and
CIP ciprofloxacin
Table 3 Predictors of ESBL carriage among 334 humans in the community in Mwanza, city
Variables Positive ESBL
carriage (55)
Univariate analysis Multivariate analysis
OR (95 % CI) P value OR (95 % CI) P value
Age(years)a 17 (IQR 6–17) 1.02 (1.2–1.3) 0.028 1.07 (1.04–1.10) <0.001
Number of childrena 4 (IQR 2–5) 1.34 (1.14–1.57) <0.001 1.15 (0.95–1.39) 0.134
Sex
Male (138) 22 (15.9 %) 1
Female (196) 33 (16.8 %) 1.06 (0.94–1.72) 0.828 1.33 (0.67–2.63) 0.410
Location
Kirumba (112) 13 (11.6 %) 1
Mbugani (66) 10 (15.2 %) 1.35 (0.49–3.59) 0.49
Igogo (156) 32 (20.5 %) 1.9 (1.0–4.2) 0.05 1.33 (0.901–1.97) 0.149
Antibiotic use
Yes (208) 44 (21.2 %) 1
No (126) 11 (8.7 %) 2.8 (1.38–5.6) 0.004 27 (6.63–116) <0.001
Admission history
No (325) 49 (15.1 %) 1
Yes (9) 6 (66.7 %) 11.3 (2.7–46.5) 0.001 7.4 (1.43–38.5) 0.017
amedian
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All but two isolates harboured tetracycline resistance
genes.
Multi locus sequence types (MLST), phylogenetic groups
and plasmid MLST
Eight different sequence types were observed in the
genome-sequenced strains (Table 4). The most common
ones were ST131 (6/25, 24 %), ST38 (5/25, 20 %) and ST-
648 (3/25, 12 %), ST2852 (3/25, 12 %), and ST617 (3/25,
12 %), Out of 25 isolates, eight (32 %) were members of
phylogroup D, seven (28 %) of phylogroup A, six (24 %) of
group B2 and four of B1.
WGS-based phylogenetic tree grouped the isolates into
three large clusters, all pathogenic E. coli (group B2 and
D) were grouped into one cluster with 14 (56 %) isolates.
The other two clusters were clonal complex (CC) ST-10
(ST-617, ST-44, all phylogenetic group A) and another
cluster with a mixture of phylogroup A (ST-4450) and B1
(ST-2852 and ST-205) (Fig. 1).
A total of 20 (80 %) isolates were found to carry IncF
plasmids which were characterized using plasmid-based
multi-locus sequence typing (pMLST) to give six different
pMLST (F1:A1:B1 (3/25), F31:A4:B1 (5/25), F1:A-:B33 (4/
25), F48:A1:B26 (2/25), F1:A1:B16 (2/25), F1:A1:B20,
F2:A1:B-, F87:A4:B1 and F46:A-:B24 variants (Table 4).
In most cases, isolates exhibiting an identical sequence
type were found to carry different plasmid types.
Virulence genes
Isolates belonging to the phylogenetic group B2 harboured
the most virulence genes followed by phylogroup D iso-
lates. Glutamate decarboxylase (gad) that confers resist-
ance to bile salts and the increased serum survival
genes (iss) were detected in 13 (52 %) of the isolates.
All phylogroup B2 isolates harboured the sat and Iha
genes encoding for a serine-protease autotransporter
and an iron-dependent adhesion protein, respectively
(Table 5).
Table 4 Resistance genes, sequence types and plasmid replicons of the sequenced isolates




RA005 ablaCTX-M-15, blaOXA-1, blaTEM-1B aadA5, aac(6’)Ib-cr, aac(3)-IIa IncFIA, IncFIB, IncFII F1:A1:B1 ST-648 D
RA023 ablaCTX-M-15 aadA5, qnrS1 IncY - ST-4450 A
RA025 ablaCTX-M-15 aadA5, qnrS1 IncY - ST-4450 A
RA034 ablaCTX-M-15, blaOXA-1, blaTEM-1B aadA5, aac(6’)Ib-cr, aac(3)-IIa IncFIA, IncFIB, IncFII F1:A1:B1 ST-648 D
RA043 blaCTX-M-15, blaTEM-1B strB, strA, qnrS1 IncY - ST-2852 B1
RA045 ablaCTX-M-15, blaOXA-1 blaTEM-1B aadA5, aac(6’)Ib-cr, aac(3)-IIa IncFIA, IncFIB, IncFII F1:A1:B1 ST-648 D
RA051 blaCTX-M-15, blaOXA-1, blaTEM-1B aadA5,aac(6’)Ib-cr, aac(3)-IIa, strA, strB IncFIA, IncFIB, IncFII F31:A4:B1 ST-617 A
RA061 ablaCTX-M-15, blaOXA-1 aadA1, aac(6’)Ib-cr, aac(3)-IIa,strA, strB IncFIB, IncFII F1:A-:B33 ST-38 D
RA073 ablaCTX-M-15, blaOXA-1 aadA5, aac(6’)Ib-cr, aac(3)-IIa,strA, strB IncFIA, IncFIB, IncFII F1:A1:B16 ST-131 B2
RA085 blaCTX-M-15, blaTEM-1B strB, strA, qnrS1 IncFIA, IncFIB, IncFII, IncY F1:A1:B20 ST-2852 B1
RA102 ablaCTX-M-15, blaOXA-1 aadA1, aac(6’)Ib-cr, aac(3)-IIa, strA, strB IncFIB, IncFII F1:A-:B33 ST-38 D
RA105 blaCTX-M-15, blaOXA-1, blaTEM-1B aadA5, aac(6’)Ib-cr, aac(3)-IId, strA,strB IncFIA, IncFIB, IncFII F87:A4:B1 ST-617 A
RA116 ablaCTX-M-15, blaOXA-1 aadA5, aac(6’)Ib-cr,aac(3)-IIa,strA, strB, IncFIB, IncFIA, IncQ1, IncFII F1:A1:B16 ST-131 B2
RA134 ablaCTX-M-15 aadA1, strA, strB No replicon ST-205 B1
RA166 blaCTX-M-15, blaOXA-1 aadA5, aac(6’)Ib-cr, aac(3)-IIa, IncFIA, IncFIB, F31:A4:B1 ST-131 B2
RA173 ablaCTX-M-15, blaOXA-1, blaTEM-1B aadA5, aac(6’)Ib-cr, aac(3)-IId, strA,strB IncFIB, IncFIA, IncQ1, IncFII F48:A1:B26 ST-131 B2
RA175 ablaCTX-M-15, blaOXA-1, blaTEM-1B aadA5, aac(6’)Ib-cr, aac(3)-IId, strA, strB IncFIA, IncFIB, IncQ1, IncFII F48:A1:B26 ST-131 B2
RA176 blaCTX-M-15, blaTEM-1B strB, strA,qnrS1 IncY - ST-38 D
RA194 blaCTX-M-15, blaOXA-1, blaTEM-1B aadA5,aac(6’)Ib-cr, aac(3)-IIa, strA, strB IncFIA, IncFIB, IncFII F31:A4:B1 ST-617 A
RA195 blaCTX-M-15, blaTEM-1B aadA1, aac(3)-IId, strB, strA IncFIB, IncFII F1:A-:B33 ST-38 D
RA217 blaCTX-M-15, blaOXA-1 aadA5, aac(6’)Ib-cr,aac(3)-IIa, strA, strB IncFIA, IncFIB, IncFII F31:A4:B1 ST-44 A
RA218 blaCTX-M-15, blaOXA-1 aadA5, aac(6’)Ib-cr,aac(3)-IIa, strA, strB IncFIB, IncFIA, IncFII F31:A4:B1 ST-44 A
RA228 ablaCTX-M-15, blaOXA-1 aadA1, aac(6’)Ib-cr, aac(3)-IIa,,strA, strB IncFIB, IncFII F1:A-:B33 ST-38 D
RA246 blaCTX-M-15, blaOXA-1, blaTEM-1B aadA5, aac(6’)Ib-cr, aac(3)-IIa, strA,strB IncFIA, IncFII F2:A1:B- ST-131 B2
RA256 blaCTX-M-15, blaTEM-1B strB, strA,qnrS1 IncY, IncFIB F46:A-:B24 ST-2852 B1
ain these isolates CTX-M-15 was located in the chromosome
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Discussion
The presented study identifies a high proportion of faecal
carriage of ESBL-producing E. coli in the Mwanza com-
munity. The prevalence of 21 % in Igogo rural district is
almost the same as that of 25 % obtained in E. coli clinical
isolates in the same town [5]. Compared to a previous
study [28] which investigated ESBL carriage in women
and neonates admitted at Bugando Medical Centre, simi-
lar findings are observed with the magnitude of carriage
observed in women. However, the carriage is significantly
lower than that obtained in neonates. Our findings are
within the range of the ESBL carriage reported in Africa
which has been found to range from 10 % in Senegal to
31 % in Niger [20, 29–31]. The high carriage in Niger
could be attributed to the fact that the population studied
suffered from malnutrition with majority of individuals
having previous antibiotic exposure.
As observed previously [18, 28], antibiotic exposure,
history of admission, or increase in age were found to
predict ESBL carriage on multivariate logistic regression
analysis in our setting as well.
As in previous studies [16, 29], the blaCTX-M-15 was
the commonest allele observed in the community in
Mwanza, Tanzania. This allele has also been found to
be the commonest allele in E. coli and Klebsiella pneu-
moniae isolates from Bugando Medical Centre [6, 32].
This could possibly be explained by contacts between
individuals admitted to the hospital, and due to the fact
that the Bugando Medical Centre is the only tertiary
hospital in the region. Also environmental contamin-
ation by hospital sewages and transfer through the
food-chain in the city such as the fish-consumption
could play a significant role [33]. This is further sup-
ported by the fact that, as in hospital E. coli isolates
from a previous study [32], ST-131 was commonly
found in the community. However, more studies are
needed to establish the transmission pathways espe-
cially the role of food-chain and environment in the
persistence and spread of ESBL isolates in the city.
Though marginally significant on univariate analysis,
people from Igogo were 1.9 times more likely to carry ESBL
isolates than those from Kirumba. The population of these
two rural districts are almost equal. However, Igogo rural
district is nearer to the Bugando Medical Centre and has
more industrial and garage activities than Kirumba. These
could contribute to more environmental contamination
that might lead to bacteria being resistant to various metals
and chemicals. In addition, the population per pharmacy/
medicine shops is low at Igogo rural district as compared
to that in Kirumba rural district; this might contribute to
an easy accessibility to antibiotics and more environmental
contamination. More research to explore human’s activities,
environmental contamination and the role of antibiotic
usage are needed. A geographical factor worth studying re-
garding the influence on ESBL carriage is the fact that in all
rural communities studied a majority of the population
lives in the hills, and use latrines that are not connected to
city sewage.
Fig. 1 Phylogenetic tree of 25 ESBL-producing E. coli based on the whole genome rooted from E. coli MG1655 genome. The tree was produced
using Harvest Suite and drawn by MEGA5 software
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As compared to hospital isolates [5, 32], E. coli isolated
in the community were more resistant to gentamicin,
sulphamethoxazole/trimethoprim and tetracycline. These
results necessitate an urgent review whether these antibi-
otics are of value for empirical treatment of infections
caused by E. coli such as urinary tract infections.
This study further confirms the role of IncF plasmids
with multiple resistance genes to be responsible in trans-
mitting resistance genes among Enterobacteriaceae isolates
[32, 34]. An important finding in this study is the detection
of IncY plasmids in 20 % of isolates carrying quinolone re-
sistance gene (qnrS1) and aminoglycosides resistance genes
(aadA5, strA and strB) in addition to blaCTX-M-15. Similar
plasmids have been recently detected in Nigeria among
healthy pregnant women [35]. In addition, 57 % (13/25) of
the isolates displayed a chromosomally located CTX-M-15,
thereby enabling a vertical transfer of the resistance. The
findings underscore the importance to investigate the
epidemiology of ESBL-producing bacteria on the African
continent to ascertain transmission pathways and factors
associated to the persistence.
Conclusion
High ESBL carriage, especially of blaCTX-M-15, is observed
in the community among Escherichia coli in Mwanza city.
Predictors for ESBL carriage are the use of antibiotic, his-
tory of hospital admission and increase in age. This infor-
mation is useful for introducing pre-admission screening,
planning empirical treatment by identifying high risk ESBL
patients and adapting empirical treatment of infections to-
wards covering ESBL isolates in patients with urosepsis.
The findings that hospital clones and plasmids are also in
the community isolates require more studies using a One
Health approach to determine the role of human’s activities
in relation to the persistence, circulation, spread and trans-
mission of CTX-M-15-producing E. coli strains in Mwanza
city in order to provide appropriate recommendations to
control this public health threat.
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Table 5 Virulence factors in relation to ST and phylogenetic
group
Isolate Sequence type Phylogroup Virulence gene
RA005 ST-648 D iha, sat, Ipfa, nfaE, gad
RA023 ST-4450 A gad, IpfA
RA025 ST-4450 A gad, IpfA
RA034 ST-648 D iha, sat, Ipfa, nfaE
RA043 ST-2852 B1 gad, IpfA
RA045 ST-648 D iha, sat, Ipfa, nfaE
RA051 ST-617 A gad, iss
RA061 ST-38 D gad, iss
RA073 ST-131 B2 iha, sat, Ipfa, nfaE, gad, senB
RA085 ST-2852 B1 gad, IpfA
RA102 ST-38 D gad, iss
RA105 ST-617 A gad, iss
RA116 ST-131 B2 iha, sat, Ipfa, nfaE, gad, senB
RA134 ST-205 B1 gad, IpfA
RA166 ST-131 B2 iha, sat, cnf1, iss, gad, senB
RA173 ST-131 B2 iha, sat, Ipfa, nfaE, gad, ireA
RA175 ST-131 B2 iha, sat, iss, nfaE, gad, ireA
RA176 ST-38 D gad, iss
RA194 ST-617 A gad, iss
RA195 ST-38 D gad, iss
RA217 ST-44 A gad, iss
RA218 ST-44 A gad, iss
RA228 ST-38 D gad, iss
RA246 ST-131 B2 nfaE, Iha, sat, gad, iss
RA256 ST-2852 B1 gad, IpfA
gad, Glutamate decarboxylase; iss, increased serum survival; iha, adherence
protein; sat, secreted autotransporter toxin; IpfA, long polar fimbriae; nfaE,
diffuse adherence fimbriae; ireA, siderophore receptor; senB, plasmid encoded
enterotoxin; cnf1, cytotoxic necrotizing factor
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